Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Cryptogenic organizing pneumonia natural history, complications and prognosis
Introduction
Overview
Overview
The symptoms of cryptogenic organizing pneumonia usually develop in the fifth or sixth decade of life and start with symptoms such as a cough, dyspnea, and weight loss. Cryptogenic organizing pneumonia patients have the good prognosis after the course of corticosteroids. Fatal outcome of cryptogenic organizing pneumonia is very rare.
Natural History, Complications, and Prognosis
Natural History, Complications, and Prognosis
Natural History
- The symptoms of cryptogenic organizing pneumonia usually develop in the fifth or sixth decade of life and start with symptoms such as a cough, dyspnea, and weight loss.
- Cryptogenic organizing pneumonia patients have the good prognosis after the course of corticosteroids. Fatal outcome of cryptogenic organizing pneumonia is very rare.
Complications
- There are no complications associated with cryptogenic organizing pneumonia but there are complications associated with corticosteroids treatment.[1]
- Complications of long-term treatment with corticosteroids therapy are:[2]
- Weight gain
- Decreased in bone density
- Muscle weakness
- Hyperlipidemia
- Growth suppression
- Thining of skin
- Diabetes
Prognosis
- Prognosis is generally good after the treatment with corticosteroids.
- Fatal outcome of cryptogenic organizing pneumonia is rare.[3]
References
References
- ↑ Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF (August 2000). “Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d’Etudes et de Recherche sur les Maladles “Orphelines” Pulmonaires (GERM”O”P)”. Am. J. Respir. Crit. Care Med. 162 (2 Pt 1): 571–7. doi:10.1164/ajrccm.162.2.9909015. PMID 10934089.
- ↑ Buchman AL (October 2001). “Side effects of corticosteroid therapy”. J. Clin. Gastroenterol. 33 (4): 289–94. PMID 11588541.
- ↑ Kim M, Cha SI, Seo H, Shin KM, Lim JK, Kim H, Yoo SS, Lee J, Lee SY, Kim CH, Park JY (July 2015). “Predictors of Relapse in Patients with Organizing Pneumonia”. Tuberc Respir Dis (Seoul). 78 (3): 190–5. doi:10.4046/trd.2015.78.3.190. PMC 4499585. PMID 26175771.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]